Bristol-Myers Squibb Company (BMY)

BMY (NYSE:Drugs) EQUITY
$55.90
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | BMY Avg Daily Volume: 8,457,000
Last Update: 06/27/17 - 4:00 PM EDT
Volume: 0
YTD Performance: -4.35%
Open: $0.00
Previous Close: $55.90
52 Week Range: $46.01 - $77.12
Oustanding Shares: 1,647,434,458
Market Cap: 93,771,969,349
6-Month Chart
TheStreet Ratings Grade for BMY
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 5 5 6 6
Moderate Buy 1 1 1 1
Hold 6 6 6 6
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 2
Mean Rec. 2.31 2.31 2.21 2.40
Latest Dividend: 0.39
Latest Dividend Yield: 2.74%
Dividend Ex-Date: 07/05/17
Price Earnings Ratio: 19.76
Price Earnings Comparisons:
BMY Sector Avg. S&P 500
19.76 19.80 30.70
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-0.25% -20.51% 13.97%
GROWTH 12 Mo 3 Yr CAGR
Revenue 17.30 0.20 0.06
Net Income 176.30 0.80 0.20
EPS 184.90 0.70 0.19
Earnings for BMY:
EBITDA 5.01B
Revenue 19.43B
Average Earnings Estimates
Qtr (06/17) Qtr (09/17) FY (12/17) FY (12/18)
Average Estimate $0.73 $0.74 $2.93 $3.05
Number of Analysts 8 7 11 10
High Estimate $0.76 $0.78 $2.97 $3.20
Low Estimate $0.70 $0.71 $2.87 $2.77
Prior Year $0.69 $0.77 $2.83 $2.93
Growth Rate (Year over Year) 6.16% -3.53% 3.66% 3.80%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
It just isn't as useful or descriptive right now.
A rotation that started as the minor chord of the rotational symphony and is now the major one.

Intermediate Level Trade: BMY Real Money Pro($)

I prefer a bullishly biased vertical call spread.
We really want to shake out the weak hands here.
The handwringers will be out in full force. Their fear creates buying opportunities.
What's right for a hedge fund manager sitting on a big gain, isn't necessarily right for you.
Bearish
May 03, 2017 | 9:08 AM EDT
Bristol-Myers was cut to "Underperform" at BMO with a $47 price target.
Bearish
May 03, 2017 | 9:08 AM EDT
Bristol-Myers was cut to "Underperform" at BMO with a $47 price target.
Let the weekend begin and may Day 2 and 3 of the NFL draft bring my Arizona Cardinals some undervalued gems on both sides of the bay. Great filling for Doug Kass over the past couple of days. Look forward to doing it again.
It doesn't look like Washington will be much help.

Columnist Conversations

this stock is showing great relative strength today, superior volume and strong price action. BOUGHT ...
If we can answer that question above we will know when this market finally corrects. The Dippers showed up aga...
If GM goes ahead with borrowing an additional $3 billion to fund the pensions... 1)  They will be tran...
I see many people negative on Nasdaq and the FANG stocks today. I have written about these stocks quite often ...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.